Detalhe da pesquisa
1.
Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study.
Clin Infect Dis;
76(3): e426-e438, 2023 02 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35607769
2.
Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier.
Blood;
135(13): 996-1007, 2020 03 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31977002
3.
In Vitro Evaluation of Rigosertib Antitumoral and Radiosensitizing Effects against Human Cholangiocarcinoma Cells.
Int J Mol Sci;
22(15)2021 Jul 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34360994
4.
Single Institution trial of anthracycline- and taxane-based chemotherapy for operable breast cancer: The ASTER study.
Breast J;
25(2): 237-242, 2019 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30810258
5.
A phase Ib study of pictilisib (GDC-0941) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with letrozole in advanced breast cancer.
Breast Cancer Res;
20(1): 109, 2018 09 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30185228
6.
Immunological characterization of a long-lasting response in a patient with metastatic triple-negative breast cancer treated with PD-1 and LAG-3 blockade.
Sci Rep;
14(1): 3379, 2024 02 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38336861
7.
Pemigatinib in previously treated solid tumors with activating FGFR1-FGFR3 alterations: phase 2 FIGHT-207 basket trial.
Nat Med;
2024 May 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38710951
8.
PROACT 2.0: A new open-source tool to improve patient-doctor communication in clinical trials.
Tumori;
: 3008916241248007, 2024 Apr 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38676437
9.
Is a dexamethasone-sparing strategy capable of preventing acute and delayed emesis caused by combined doxorubicin and paclitaxel for breast cancer? Analysis of a phase II trial.
Oncology;
84(6): 371-7, 2013.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23711719
10.
Molecular Tumor Board as a Clinical Tool for Converting Molecular Data Into Real-World Patient Care.
JCO Precis Oncol;
7: e2300067, 2023 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37487147
11.
Targeted protein degraders from an oncologist point of view: The Holy Grail of cancer therapy?
Crit Rev Oncol Hematol;
169: 103532, 2022 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34800655
12.
Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model.
Front Oncol;
12: 857515, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35463374
13.
Targeted RNA-sequencing analysis for fusion transcripts detection in tumor diagnostics: assessment of bioinformatic tools reliability in FFPE samples.
Explor Target Antitumor Ther;
3(5): 582-597, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36338518
14.
Efficacy of mRNA anti-SARS-CoV-2 vaccination and dynamics of humoral immune response in patients with solid tumors: results from the institutional registry of an Italian tertiary cancer center.
Ther Adv Med Oncol;
14: 17588359221108687, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35923922
15.
Nomogram to predict the outcomes of patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors.
J Immunother Cancer;
9(8)2021 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34429334
16.
Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study.
J Clin Oncol;
39(27): 2991-3001, 2021 09 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34292792
17.
A Phase 1 Study of mTORC1/2 Inhibitor BI 860585 as a Single Agent or with Exemestane or Paclitaxel in Patients with Advanced Solid Tumors.
Cancers (Basel);
12(6)2020 May 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32486385
18.
Combination of Baseline LDH, Performance Status and Age as Integrated Algorithm to Identify Solid Tumor Patients with Higher Probability of Response to Anti PD-1 and PD-L1 Monoclonal Antibodies.
Cancers (Basel);
11(2)2019 Feb 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30769874
19.
Publisher Correction: Pemigatinib in previously treated solid tumors with activating FGFR1-FGFR3 alterations: phase 2 FIGHT-207 basket trial.
Nat Med;
2024 May 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38789647
20.
Ascites During Selpercatinib Treatment: Need for a Multidisciplinary Approach.
J Thorac Oncol;
18(2): e9-e10, 2023 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36682848